Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 52 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 81 | 3,603−6.4%/yr | −6.4%/yr | 2.50.8× | 7% | 3,990 in 2030+1.7%/yr |
| Lumbar fusion | 71 | 3,069−2%/yr | −2%/yr | 2.20.8× | 1% | 3,410 in 2030+1.8%/yr |
| Kyphoplasty & vertebroplasty | 22 | 1,781−6.9%/yr | −6.9%/yr | 1.30.9× | 16% | 1,860 in 2030+0.7%/yr |
| Cervical fusion & disc arthroplasty | 28 | 1,515−7.1%/yr | −7.1%/yr | 1.10.8× | 2% | 1,670 in 2030+1.6%/yr |
| SI joint fusion | 2 | 171+8.4%/yr | +8.4%/yr | 0.10.5× | 0% | 380 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 639 | 135,945−2.4%/yr | −2.4%/yr | 94.51.2× | 44% | 136,300 in 20300%/yr |
| Skin substitutes & wound grafts | 83 | 23,783+12%/yr | +12%/yr | 11.51.7× | 50% | 36,600 in 2030+7.5%/yr |
| Bone graft & orthobiologics | 16 | 682−8.3%/yr | −8.3%/yr | 0.50.7× | 1% | 720 in 2030+0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 165 | 12,036+1%/yr | +1%/yr | 8.40.9× | 66% | 13,800 in 2030+2.3%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 14 | 1,015+11%/yr | +11%/yr | 0.70.6× | 41% | 2,110 in 2030+13%/yr |
| Spinal cord & DRG stimulation | 20 | 692−5.2%/yr | −5.2%/yr | 0.50.6× | 47% | 820 in 2030+2.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Superficial venous ablation | 97 | 8,273−2.9%/yr | −2.9%/yr | 5.82.0× | 94% | 9,750 in 2030+2.8%/yr |
| Dialysis access | 87 | 7,931−11%/yr | −11%/yr | 5.91.4× | 73% | 7,380 in 2030−1.2%/yr |
| Peripheral arterial intervention | 47 | 6,194−7.5%/yr | −7.5%/yr | 4.31.0× | 41% | 6,330 in 2030+0.4%/yr |
| Thrombectomy, IVC filters & venous stents | 28 | 2,235+1.2%/yr | +1.2%/yr | 1.61.2× | 18% | 3,030 in 2030+5.2%/yr |
| Carotid revascularization | 31 | 1,439−3.9%/yr | −3.9%/yr | 1.00.9× | 0% | 1,600 in 2030+1.8%/yr |
| Aortic endografts (EVAR/TEVAR) | 7 | 563−7.4%/yr | −7.4%/yr | 0.40.8× | 0% | 600 in 2030+1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 88 | 7,166−3.6%/yr | −3.6%/yr | 5.50.9× | 7% | 8,010 in 2030+1.9%/yr |
| Cholecystectomy & appendectomy | 106 | 4,982−6.5%/yr | −6.5%/yr | 3.70.8× | 2% | 5,420 in 2030+1.4%/yr |
| Colorectal resection | 7 | 2,192−5.2%/yr | −5.2%/yr | 1.60.9× | 0% | 1,930 in 2030−2.1%/yr |
| Antireflux & hiatal hernia surgery | 12 | 791−1.1%/yr | −1.1%/yr | 0.60.7× | 0% | 930 in 2030+2.8%/yr |
| Breast reconstruction | 3 | 597−7.9%/yr | −7.9%/yr | 0.41.1× | 0% | 1,560 in 2030+17%/yr |
| Bariatric surgery | 0 | 277−14%/yr | −14%/yr | 0.21.0× | 0% | 160 in 2030−9.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 148 | 6,158−2.8%/yr | −2.8%/yr | 4.50.8× | 13% | 6,630 in 2030+1.2%/yr |
| BPH procedures | 93 | 5,993−6.1%/yr | −6.1%/yr | 4.30.9× | 36% | 5,880 in 2030−0.3%/yr |
| Hysterectomy, hysteroscopy & ablation | 30 | 3,307−3.1%/yr | −3.1%/yr | 2.60.8× | 12% | 3,820 in 2030+2.4%/yr |
| Incontinence, prolapse & sacral neuromodulation | 39 | 2,574−0.2%/yr | −0.2%/yr | 1.90.8× | 8% | 3,390 in 2030+4.7%/yr |
| Prostatectomy & nephrectomy | 22 | 1,462−0.6%/yr | −0.6%/yr | 1.10.8× | 0% | 1,710 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 41 | 5,453+5.6%/yr | +5.6%/yr | 4.01.1× | 88% | 8,180 in 2030+7%/yr |
| Sleep apnea & airway implants | 5 | 187+137%/yr | +137%/yr | 0.10.6× | 0% | 160 in 2030−2.3%/yr |
| Cochlear implants | 4 | 174+4.9%/yr | +4.9%/yr | 0.10.6× | 0% | 140 in 2030−3.2%/yr |
| Ear tubes & middle ear surgery | 1 | 167−17%/yr | −17%/yr | 0.10.3× | 14% | 260 in 2030+7.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 165 | 9,253−2.3%/yr | −2.3%/yr | 7.11.0× | 8% | 9,520 in 2030+0.5%/yr |
| Tumor & fibroid embolization | 14 | 674+3.6%/yr | +3.6%/yr | 0.50.9× | 49% | 1,750 in 2030+17%/yr |
| Tumor ablation | 2 | 357+0.9%/yr | +0.9%/yr | 0.30.8× | 0% | 740 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 293 | 40,924+22%/yr | +22%/yr | 29.21.1× | 76% | 73,100 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 127 | 6,690−0.8%/yr | −0.8%/yr | 5.00.9× | 4% | 6,500 in 2030−0.5%/yr |
| EP ablation | 109 | 5,700+7.4%/yr | +7.4%/yr | 3.61.2× | 0% | 10,500 in 2030+11%/yr |
| LAA occlusion & loop recorders | 125 | 4,051+13%/yr | +13%/yr | 2.60.8× | 15% | 6,990 in 2030+9.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 214 | 9,057−5.7%/yr | −5.7%/yr | 5.50.9× | 1% | 9,710 in 2030+1.2%/yr |
| Structural heart (TAVR, TEER) | 119 | 2,664+7.3%/yr | +7.3%/yr | 1.70.9× | 0% | 3,910 in 2030+6.6%/yr |
| Mechanical circulatory support | 6 | 983−2.7%/yr | −2.7%/yr | 0.71.2× | 0% | 910 in 2030−1.3%/yr |
| PFO & septal closure | 0 | 116+4.3%/yr | +4.3%/yr | 0.10.9× | 0% | 80 in 2030−5.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 17 | 594+15%/yr | +15%/yr | 0.41.0× | 0% | 1,210 in 2030+13%/yr |
| Stroke thrombectomy | 25 | 589+1.7%/yr | +1.7%/yr | 0.41.0× | 0% | 610 in 2030+0.7%/yr |
| DBS & VNS | 4 | 294−8.4%/yr | −8.4%/yr | 0.20.6× | 0% | 330 in 2030+2.2%/yr |
| CSF shunts | 1 | 244−3.5%/yr | −3.5%/yr | 0.20.9× | 0% | 310 in 2030+4.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 317 | 67,303−0.8%/yr | −0.8%/yr | 48.00.7× | 70% | 75,800 in 2030+2%/yr |
| Vitreoretinal surgery | 31 | 2,737−5.7%/yr | −5.7%/yr | 2.00.8× | 42% | 2,740 in 20300%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 754 | 159,886−2.7%/yr | −2.7%/yr | 119.61.1× | 31% | 174,100 in 2030+1.4%/yr |
| Bronchoscopy & lung nodule | 82 | 5,581+11%/yr | +11%/yr | 4.11.1× | 0% | 10,800 in 2030+12%/yr |
| ERCP & endoscopic ultrasound | 80 | 5,038−0.4%/yr | −0.4%/yr | 3.70.9× | 1% | 6,770 in 2030+5.1%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.